Business
Acadia Pharmaceuticals Inc (ACAD) Stock: What the Analysts are Saying
Acadia Pharmaceuticals Inc (NASDAQ: ACAD) has a price-to-earnings ratio that is above its average at 16.60x. The stock has a 36-month beta value of 0.65.
Acadia Pharmaceuticals Inc (NASDAQ: ACAD) has a price-to-earnings ratio that is above its average at 16.60x. The stock has a 36-month beta value of 0.65.
Acadia Pharmaceuticals Inc (NASDAQ: ACAD)’s stock price has plunge by -0.45relation to previous closing price of 22.30. Nevertheless, the company has seen a 1.00% surge
The stock of Acadia Pharmaceuticals Inc (ACAD) has gone down by -1.14% for the week, with a 43.79% rise in the past month and a
Acadia Pharmaceuticals Inc (NASDAQ: ACAD)’s stock price has gone rise by 26.48 in comparison to its previous close of 17.60, however, the company has experienced
© 2024, Powered by Smart TechOne